These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31402469)

  • 41. Methodological and clinical aspects of alloimmunization after granulocyte transfusion in patients undergoing allogeneic stem cell transplantation.
    Flaxa J; Rosner A; Hölig K; Bornhäuser M; Wassmuth R
    Tissue Antigens; 2015 Feb; 85(2):93-103. PubMed ID: 25515298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience.
    Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z
    Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of G-CSF for granulocyte transfusion therapy.
    Hübel K; Dale DC; Engert A; Liles WC
    Cytokines Cell Mol Ther; 2000 Jun; 6(2):89-95. PubMed ID: 11108574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Influences of FLU/BU and FLU/MEL on incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients].
    Torihata S; Mukai T; Uchihashi T; Matsunaga K; Miki H; Yasumoto M; Yasutake N; Ashida A; Enomoto A; Hamada S; Ashida T
    Rinsho Ketsueki; 2017; 58(3):197-203. PubMed ID: 28381685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II study.
    Guberti M; Botti S; Caffarri C; Cavuto S; Savoldi L; Fusco A; Merli F; Piredda M; De Marinis MG
    Ann Hematol; 2022 Oct; 101(10):2325-2336. PubMed ID: 35922679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current Practice of Oral Care for Hematopoietic Stem Cell Transplant Patients: A Survey of the Eastern Mediterranean Blood and Marrow Transplantation Group.
    Mawardi H; Treister N; Felemban O; Alamoudi W; Algohary G; Alsultan A; Alshehri N; Tazi I; Shaheen M; Alsharani M; Alshemmari S; Arat M; Bekadja MA; Al-Khabori M; Okaily S; Ali N; Abujazar H; Jastaniah W; Hamidieh AA; Hashmi S; Aljurf M
    Hematol Oncol Stem Cell Ther; 2023 Jan; 16(1):42-51. PubMed ID: 36634283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective longitudinal analysis of clinical and immunological risk factors associated with oral and gastrointestinal mucositis following autologous stem cell transplant in adults.
    Wong SP; Tan SM; Lee CS; Law KB; Lim YAL; Rajasuriar R
    Support Care Cancer; 2023 Jul; 31(8):494. PubMed ID: 37498423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Oral and Gastrointestinal Mucositis on Body Weight Alterations during Hematopoietic Stem Cell Transplantation.
    Eduardo FP; Bezinelli LM; Gobbi MF; Pereira AZ; Vogel C; Hamerschlak N; Corrêa L
    Nutr Cancer; 2018; 70(2):241-248. PubMed ID: 29278934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD.
    Sugita J; Matsushita T; Kashiwazaki H; Kosugi M; Takahashi S; Wakasa K; Shiratori S; Ibata M; Shono Y; Shigematsu A; Obara M; Fujimoto K; Endo T; Nishio M; Kondo T; Hashino S; Tanaka J; Asaka M; Imamura M
    Bone Marrow Transplant; 2012 Feb; 47(2):258-64. PubMed ID: 21423118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progress of oral care and reduction of oral mucositis--a pilot study in a hematopoietic stem cell transplantation ward.
    Soga Y; Sugiura Y; Takahashi K; Nishimoto H; Maeda Y; Tanimoto M; Takashiba S
    Support Care Cancer; 2010 Feb; 19(2):303-7. PubMed ID: 20842384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation.
    Bezinelli LM; de Paula Eduardo F; da Graça Lopes RM; Biazevic MG; de Paula Eduardo C; Correa L; Hamerschlak N; Michel-Crosato E
    Hematol Oncol; 2014 Mar; 32(1):31-9. PubMed ID: 23625880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation.
    Elad S; Ackerstein A; Bitan M; Shapira MY; Resnick I; Gesundheit B; Cohen Y; Diss O; Barak D; Dray L; Or R
    Bone Marrow Transplant; 2006 Apr; 37(8):757-62. PubMed ID: 16518424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    Support Care Cancer; 2007 May; 15(5):491-6. PubMed ID: 17139495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
    Shouval R; Eshel A; Dubovski B; Kuperman AA; Danylesko I; Fein JA; Fried S; Geva M; Kouniavski E; Neuman H; Armon-Omer A; Shahien R; Muller E; Noecker C; Borenstein E; Louzoun Y; Nagler A; Koren O
    Blood Adv; 2020 Jul; 4(13):2912-2917. PubMed ID: 32598476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in the understanding and management of mucositis during stem cell transplantation.
    Bowen JM; Wardill HR
    Curr Opin Support Palliat Care; 2017 Dec; 11(4):341-346. PubMed ID: 28984677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The non-steroidal anti-inflammatory drug salsalate provides safe and effective control of mucositis-unrelated pain during autologous and allogeneic hematopoietic stem cell transplantation.
    Trifilio S; Gordon L; Rubin H; Grosshans N; Mehta J
    Support Care Cancer; 2021 Jul; 29(7):3643-3648. PubMed ID: 33179136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
    J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of low power laser in the treatment of conditioning-induced oral mucositis: a report of 11 clinical cases and their review.
    Antunes HS; Ferreira EM; de Matos VD; Pinheiro CT; Ferreira CG
    Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E189-92. PubMed ID: 18305441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of life related to oral mucositis of patients undergoing haematopoietic stem cell transplantation and receiving specialised oral care with low-level laser therapy: a prospective observational study.
    Bezinelli LM; Eduardo FP; Neves VD; Correa L; Lopes RM; Michel-Crosato E; Hamerschlak N; Biazevic MG
    Eur J Cancer Care (Engl); 2016 Jul; 25(4):668-74. PubMed ID: 26087364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.